相关实验视频
Updated: Jan 10, 2026

Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
长期咳治疗中的加巴丁:元分析洞察力
Dongxu Si1, Wenfeng He2, Hui Yu1
1Department of Pulmonary and Critical Care Medicine II, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou , China.
神经调节剂显著改善生活质量,并减少患有难治性或不明原因慢性咳 (R/UCC) 患者的咳频率. 较长的治疗持续时间,比如12周,显示出更大的有效性,加巴丁是特别有益的.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐药或无法解释的慢性咳 (R/UCC) 具有有限的治疗选择.
- 人们对当前治疗慢性咳的药物的安全性存在担忧.
研究的目的:
- 通过元分析评估神经调节剂对R/UCC的疗效和安全性.
- 为了确定最佳的治疗持续时间和特定的神经调节剂,用于慢性咳管理.
主要方法:
- 进行了对9项随机对照试验 (RCT) 的元分析.
- 该研究分析了神经调节剂对慢性咳症状,生活质量 (莱斯特咳问卷 - LCQ) 和咳频率的影响.
主要成果:
- 神经调节剂显著改善了生活质量 (MD在LCQ得分:3.21) 并减少了24小时咳频率 (MD: -7.91).
- gabapentin 显示了最显著的改善.
- 长达12周的治疗时间比较短的时间更有效.
结论:
- 神经调节剂在治疗R/UCC方面具有临床有效性.
- 较长的治疗时间和像 gabapentin 这样的特定药物可以提高疗效.
- 需要进一步的研究来探索患者的变化和优化治疗策略.
更多相关视频
05:43Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
Published on: January 10, 2025
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...